CREKA peptide TFA
CREKA peptide TFA is a trifluoroacetic acid form of a short peptide with self-assembling properties. The peptide sequence is Cys-Arg-Glu-Lys-Ala (CREKA). This short peptide can specifically recognize and bind to overexpressed fibrin in diseased tissues, thereby enabling targeted localization to pathological sites. Studies have shown that CREKA peptide can effectively target regions associated with cancer, myocardial ischemia-reperfusion injury, and atherosclerosis. Due to its excellent targeting ability and self-assembly characteristics, CREKA peptide has broad application prospects in the field of nanomedicine. It can be used to construct targeted drug delivery systems, diagnostic imaging probes, and therapeutic nanomaterials, offering the potential to improve the precision and efficacy of disease diagnosis and treatment.
| Storage | Store at -20°C |
| M.Wt | 665.76 |
| Cas No. | 847058-45-1 |
| Formula | C25H47N9O10S |
| Chemical Name | (6S,9S,12S,15S)-1-amino-6-((R)-2-amino-3-mercaptopropanamido)-12-(4-aminobutyl)-9-(2-carboxyethyl)-1-imino-15-methyl-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid--acetic acid (1/1) |
| SDF | Download SDF |
| Canonical SMILES | SC[C@H](N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O.CC(O)=O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
-
Purity = 98.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
